Michael Carrette, Caroline de Costa, Philip Goldstone, Mukesh Haikerwal
Issue 6 / 16 February 2026
February 2026 marks the twentieth anniversary of the overturning of the Harradine Amendment by the Federal Parliament in 2006. Thanks to the efforts of many people across the country, this parliamentary action opened the way for a cascade of reforms in abortion care for Australian women.
The 1996 Amendment to the 1989 Therapeutic Goods Act was a political measure initiated by Brian Harradine, independent senator for Tasmania, who held the balance of power in the Senate during the Howard government and who was a hostile opponent of abortion. At the time, mifepristone (better known then as RU486) had been used in Australia only for a small clinical trial by Monash professor David Healy. Harradine made a deal with then Prime Minister, John Howard — he would support Howard’s bill to privatise Telstra and in return Howard would bring in legislation forbidding the import, manufacture or use of mifepristone in Australia without the express permission of the Health Minister. The Amendment was passed and had the effect of completely blocking efforts to introduce mifepristone for medical abortion in Australia, despite increasing use of mifepristone in many overseas countries and its proven safety.